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Since 1883 (1) when Ehrlich first demonstrated the renaltubular changes in 
diabetic patients to be glycogen nephrosis, this lesion has been accepted as the 
principal anatomic evidence of diabetes mellitus at postmortem examination. 
However, at present there is some disagreement as to whether glycogen nephro- 
sis is a specific lesion of diabetes mellitus (2) or merely an anatomic reflection 
of glycosuria 0). 
With the advent of insulin therapy a definite decrease in both the incidence 
and severity of glycogen nephrosis in diabetic patients was noted at autopsy 
(4).  It has been assumed therefore that the appearance of this substance in the 
renal tubular epithelium of diabetic patients must be related to the severity of 
glycosuria.  This impression has been borne out as progressive improvement 
in the control of diabetic patients has made glycogen nephrosis an increasingly 
uncommon  finding.  In  a  series  of  postmortem  examinations  on  diabetic 
patients performed from 1932 to 1942 (2) only a 42 per cent incidence of glyco- 
gen nephrosis was found, in contrast to  the pre-insulin finding of glycogen 
nephrosis in practically every kidney of diabetics.  Save for these morphologic 
observations little is known about the cause of this lesion. 
With the introduction of the drug, alloxan, as a medium of reproducing in 
animals diabetic lesions comparable to those of humans with diabetes mellitus, 
it became possible to study the development of glycogen nephrosis.  Specifi- 
cally, it was our desire to investigate the following  aspects of glycogen nephrosis 
in experimentally induced diabetes: (a) The frequency of its occurrence in a 
series of diabetic rats.  (b) The rapidity with which it develops following the 
onset of diabetes.  (e) The existence of any correlation between the occurrence 
of glycogen nephrosis  and  the  initial postinjection levels  of hyperglycemia. 
(d)  The relationship of the incidence of glycogen nephrosis to the maximum 
blood sugar levels attained by individual rats.  (e)  The relationship of the 
occurrence  of  glycogen nephrosis  to  the  terminal  blood  sugar  levels.  (f) 
Whether glycogen nephrosis as it occurs in diabetic rats is a reversible lesion. 
Material and Methods 
All studies were performed  on young, 180 to 220 gin. albino male and female rats.  The 
method used for the production  of the diabetes  in these animals varied from the administra- 
tion of one massive  dose  of alloxan  monohydrate  to the administration  of repeated small  doses 
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over  a  period  of  time.  All  injections were  given subcutaneously.  These  technics were 
employed in an effort to obtain many different levels of hyperglycemia.  The largest single 
dose used was  200 rag. of alloxan per kilo of body weight.  The smallest was  140 mg. per 
kilo of body weight.  Using these smaller doses it was possible by the administration of 
multiple injections to raise repeatedly the level of the blood sugar.  If the individual rat 
responded at all to the initial injection of alloxan, subsequent injections would produce suc- 
cessive increases in the hyperglycemia until the desired level was attained. 
The rats were fed a diet of commercial rat pellets and water ad libilum.  Fifteen control 
animals receiving no alloxan were maintained under identical conditions. 
The animals were sacrificed at times of election by a blow on the head, and sections of 
kidney, liver, and pancreas were fixed as routine in Zenker's solution, 10 per cent formalin, 
and absolute  alcohol.  Slides of all tissues were  prepared with phloxine methylene  blue 
stains.  Best's carmine stain was used on the kidney sections to demonstrate the presence of 
glycogen (5).  The severity of the diabetes was followed by repeated blood and urine sugar 
determinations, with occasional acetone  determinations.  The Folin-Malmros blood sugar 
micromethod (6) was used on the tail blood samples, and a routine Benedict's qualitative test 
was used on the urine for the demonstration of glycosuria. 
KESULTS 
A total of two hundred and seven rats were injected with alloxan, of which 
seventy-six,  or  37  per  cent,  survived  the  immediate  postinjection  period. 
Only three of these seventy-six surviving rats failed to develop hyperglycemia, 
that is, levels of blood sugar over 150 mg. per cent.  With regard to the three 
alloxan-resistant rats, it was found that if the animals failed to react to the 
initial dose of alloxan, repeated larger doses would also have no diabetogenic 
effect.  Some of the diabetic rats were not autopsied soon enough after death 
to obtain satisfactorily fixed tissues and hence only sixty-two animals are re- 
ported upon in this study, of which three are the previously mentioned alloxan- 
resistant, non-diabetic rats. 
Using the previously described technics, blood sugar values from the mini- 
mum hyperglycemic level of 150 rag. per cent up to a maximum level of 1200 
mg. per cent were achieved.  This last value was so unexpected that blood 
samples were sent to an independent laboratory for corroboration and were 
found to be correct. 
The periods of observation of these diabetic rats, beginning at the time of the 
initial injection of aUoxan, varied from 5 days to 32 weeks.  Table I  indicates 
the distribution and height of the terminal blood sugar levels as they related to 
to the length of the diabetic period in  individual rats.  It can be seen from 
this table that most of the diabetic rats died with terminal sugar levels between 
250 to 499 rag. per cent, with the highest level 1200 mg. per cent.  For the most 
part the animals were sacrificed at the end of a 6 week period of observation. 
However, a few rats were maintained for as long as 32 weeks. 
Glycogen stains on the kidneys of the fifty-nine diabetic animals revealed 
nephrosis in twenty-six, or 44.0 per cent.  The glycogen was found in the loop 
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demonstrated  within  the  glomeruli.  No lesions  suggestive of intercapillary 
glomerulosclerosis were noted. 
In an effort to determine how rapidly glycogen nephrosis becomes anatomi- 
caUy evident after the onset of diabetes, a  group of eight rats were sacrificed 
between 5 to 9 days after the administration of a single dose of alloxan.  Table 
Distribution 
Time of experimental  diabetes, Irks.  Terminal  blood 
sugar levels 
1-2  I  8-10 
rag. per cent 
~0--149 
150-249 
250-349 
350-449 
450-549 
55O-649 
1200 
TABLE I 
"  Rcgs in Rdogion to Their Terminal Blood Sugar Levels and Dura¢ion ofDiabeles 
i 
1  1  ! 
I  1  2  2 
5  1  2 
8  '  2 
4  1  1 
1  1  ! 
20  8  6 
10-12  13-14 
1  1 
]  1  1 
32  Total 
3 
12 
17 
17 
8 
4 
I 
Total .....  14  12 
TABLE II 
Speed of Develo~raent of Glycogen Nephrosis 
Rat No.  Duration  of diabetes  Blood sugar  Glycogen in kidneys 
19 
21 
20 
54 
22 
23 
42 
33 
days 
5 
5 
5 
6 
8 
8 
9 
9 
~n&.  l~er  I00 cc. blood 
364 
320 
400 
1200 
420 
302 
254 
527 
0 
0 
.4_ 
+++ 
0 
0 
0 
+++ 
II demonstrates the development of the glycogen nephrosis within these time 
intervals in relation to the terminal blood sugar levels of the individual rat. 
In a general way, it can be observed that the development of glycogen nephro- 
sis, as indicated by histologic methods, is a function of the severity of the hyper- 
glycemia and its duration. 
During the period of observation of the diabetic rats it was noted that some 
of the animals receiving an initial single injection of aUoxan continued to become 
more severely diabetic with blood sugar levels rising progressively throughout 
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an initial response  showed progressively  failing sugar levels, some becoming 
apparently non-diabetic.  This tendency  of the blood sugar to return to normal 
levels was not limited to the single injection group, but was also observed at the 
termination of the course of alloxan in rats receiving several injections.  This 
variability in course of the disease appeared to be a function of the individual 
rat. 
It was also apparent that the rats with falling blood sugar levels frequently 
showed  no glycogen deposits  in their kidneys at the time of sacrifice.  To 
determine whether the glycogen  nephrosis  in any individual rat was most 
closely correlated with the initial postinjection hyperglycemia, the maximum 
hyperglycemia attained by the animal at any time, or the terminal hypergly- 
cemia, the blood sugar trends of each of twenty-six rats, diabetic for periods 
of 2 weeks or longer, were charted, indicating at the time of sacrifice whether 
glycogen nephrosis was present or absent (Chart 1).  This chart demonstrates 
that these twenty-six animals could be divided into three groups. 
Group 1: These rats started with initial low levels of blood sugar and showed 
progressively rising hyperglycemia.  If the levels of blood sugar at the time of 
sacrifice  were  above  350  rag.  per  cent, glycogen  was  found in  the  renal 
epithelium. 
Group 2: These rats started with high levels of blood sugar (above 500 rag. 
per  cent)  and  showed  progressively  failing levels.  If  these  animals were 
sacrificed with terminal levels above 350 rag. per cent, glycogen nephrosis was 
present, whereas if the terminal levels were below 300 rag. per cent, no glycogen 
could be demonstrated. 
Group  3: This group of rats maintained fairly constant levels  of hyper- 
glycemia throughout their diabetic courses.  As noted above,  those rats with 
sugar levels above 350 rag. per cent showed glycogen nephrosis while those with 
terminal sugar levels below 300 mg. per cent showed no glycogen deposits. 
DISCUSSION 
The 37 per cent survival rate of rats after injection of alloxan monohydrate 
for the production of experimental diabetes agrees well with other authors in 
this field.  The causes of the immediate postinjection mortality are twofold: 
the one being diabetic reactions resulting from too great destruction of the islets, 
and the other being uremia, which frequently supervenes on the basis of wide- 
spread renal tubular necrosis (7).  The single large dose of alloxan produced 
most of these fatalities in the present study. 
The response of any individual rat to the aUoxan was completely unpredict- 
able.  Some animals, three, proved to be alloxan-resistant; others gave widely 
differing responses, with all levels of hyperglycemia  up to the level of 1200 nag. 
per cent.  These reactions had the character of individual variations and could 
not be correlated with the age or size of the animal, or the size of the dia- 
betogenic dose. G.  W.  CUET,IS~  S. L. ROBBINS~  AND  I. GLIC~AN  377 
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The glycogen nephrosis produced in these experimental rats, which occurred 
in 44.0 per cent of the animals, exactly resembled the lesions found in patients 
dying with  diabetes mellitus (8).  It was limited to the tubular epithelium, 
chiefly in Henle's loops and in the convoluted tubules.  Glycogen deposits in 
the glomeruli, described  as occurring occasionally  in human beings,  were not 
found in these experimental lesions.  In those animals proving refractory to 
alloxan and failing to develop diabetes, despite repeated administrations of the 
drug, no glycogen deposits  were found, ruling out the possibility that these 
deposits were in any way related to any toxic effects of alloxan.  Moreover, 
microscopic sections of the kidneys of the control animals revealed no glycogen 
deposits. 
It is of interest to note that no intercapillary glomerulosclerosis was observed 
within the time limits of this experiment. 
In no instance was it possible to detect glycogen nephrosis in animals which 
had been diabetic for less than 5 days.  This observation is in agreement with 
those of others who report its first appearance after 4 days of experimental 
diabetes.  Beyond the initial 5 day period the severity and rapidity with which 
glycogen nephrosis developed in rats which received a single injection of alloxan 
were correlated with both the level and the duration of hyperglycemia. 
It seems safe to assume that an increase in blood sugar above a certain level is 
required before the time factor becomes effective in determining the appearance 
of renal glycogen.  For example, no glycogen was observed in animals diabetic 
for long periods  of time (74 days) with levels of blood sugar below 300 rag. 
per cent. 
In animals diabetic for more than 9 days, the single factor with which the 
postmortem finding of glycogen nephrosis could be correlated, was the terminal 
blood sugar level.  In all animals, with rare exception, glycogen nephrosis was 
observed  associated  with terminal blood sugar levels of 350 rag. per cent or 
above (Chart I).  This correlation was observed regardless of whether the trend 
of the hyperglycemia was rising or falling at the time of sacrifice.  Moreover, 
this relationship between glycogen nephrosis and terminal blood sugar level was 
observed  i~espective of the initial blood sugar level or the height which the 
blood sugar may have attained at any time in the course of experimental dia- 
betes  in  individual animals.  The  fact that  glycogen  nephrosis  apparently 
requires a terminal blood sugar level considerably  above the normal indicates 
that the deposition of glycogen within the renal tubular epithelium is not merely 
an anatomic reflection  of the existence of any degree of  hyperglycemia.  If 
these observations can be applied to diabetes as it occurs in human beings, then 
one may infer that the autopsy finding of glycogen within the  renal tubular 
epithelium depends chiefly upon a pronounced terminal diabetic state rather 
than the antecedent diabetic course. 
The findings in this experiment further suggest that glycogen nephrosis is a 
reversible lesion.  As has been pointed out above, a terminal blood sugar level G.  W.  CURTIS,  S.  L.  ROBBINS~  AND  I.  GLICKM.AN  379 
of over 350 mg. per cent was invariably associated with a postmortem finding of 
glycogen nephrosis.  Some animals started with initial  blood sugar levels of 
over 500 rag. per cent and showed progressively falling hyperglycemia.  Glyco- 
gen nephrosis was not found at autopsy when the terminal blood sugar level 
fell below 300  rag.  per cent.  The inference  seems warranted  that  if  these 
animals had been sacrificed at some time during the course of the diabetic period 
when the blood sugar level was over 350 rag. per cent, glycogen nephrosis would 
have  been encountered.  The  findings  strongly suggest  the  reversibility of 
glycogen deposition within the kidneys.  Further study of this point is now in 
progress. 
SUMMARY 
Two hundred and seven albino rats were injected subcutaneously with alloxan 
in doses varying from 140 to 200 rag. per cent per kilo of body weight.  Fifty- 
nine animals  which developed hyperglycemia  (blood sugar levels above  150 
rag. per cent) were observed for periods from 5 days to 32 weeks. 
Postmortem examination of the kidneys of these diabetic animals  revealed 
glycogen deposition in the loops of Henle and convduted tubules in 26 rats or 
44 per cent.  Glycogen could not be demonstrated in the glomeruli.  Within 
the time limits of this experiment (32 weeks) no intercapillary glomerulosclero- 
sis was observed. 
The following  facts were revealed regarding  glycogen nephrosis in alloxan 
diabetes: 
(a)  Its appearance in the kidneys of the diabetic rats depended solely upon 
the terminal blood sugar levels of these animals.  A value of 350 rag. per cent 
was the critical level,  above which glycogen nephrosis was almost invariably 
demonstrable.  With terminal levels below 300 rag.  per cent no glycogen ne- 
phrosis was found. 
(b)  No relationship  existed between the postmortem  finding  of  glycogen 
nephrosis  and  the  initial  blood sugar level,  or  the maximum  height  of the 
hyperglycemia attained by individual rats. 
(c)  The results suggest that glycogen nephrosis is a reversible lesion. 
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